Safety and Efficacy of Intravenous Valproate in Pediatric Status Epilepticus and Acute Repetitive Seizures
NCT01268904 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2010-12-31
Summary
To evaluate the safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures as part of seizure treatment protocol in pediatric ER
Conditions
- Status Epilepticus
Interventions
- DRUG
-
Intravenous valproate application to pediatric patients suffering from status epilepticus and acute repetitive seizures
Sponsors & Collaborators
-
Hillel Yaffe Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 6 Months
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2013-07-31
- Completion
- 2013-08-31
Countries
- Israel
Study Locations
More Related Trials
-
Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures
NCT00004817 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures
NCT04903314 ·Status: COMPLETED ·Phase: PHASE1
-
Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion
NCT04529954 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety and Tolerability of Valproic Acid in Healthy Volunteers (Part 1)
NCT01951560 ·Status: COMPLETED ·Phase: PHASE1
-
IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures
NCT00510783 ·Status: COMPLETED ·Phase: PHASE4
-
Lorazepam for the Treatment of Status Epilepticus in Children
NCT00114569 ·Status: COMPLETED ·Phase: PHASE1
-
Open-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
NCT00505934 ·Status: COMPLETED ·Phase: PHASE2
-
Seizures Post Intracerebral Hemorrhage
NCT01115959 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Tolerability of Valproic Acid in Trauma Patients(Part 2)
NCT02872428 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.
NCT00425282 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
NCT04666610 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Intravenous Phenobarbital in Neonatal Seizures
NCT04320940 ·Status: TERMINATED ·Phase: PHASE3
-
A Dose Ranging Pilot Study for Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Temporal Seizures
NCT02899611 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures
NCT00275912 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR
NCT00368069 ·Status: COMPLETED ·Phase: PHASE3
-
Valproate Response in Aggressive Autistic Adolescents
NCT00065884 ·Status: UNKNOWN ·Phase: PHASE3
-
Valproate for the Treatment of Residual Amblyopia
NCT07226141 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Valproate in Young Patients Suffering From Epilepsy
NCT00385411 ·Status: COMPLETED ·Phase: PHASE4
-
Pediatric Epilepsy Trial in Subjects 1-24 Months
NCT00043875 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2)
NCT00621478 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Safety, Tolerability and Efficacy of Oral Administration of PTL101 (Cannabidiol) as an Adjunctive Treatment for Pediatric Intractable Epilepsy
NCT02987114 ·Status: COMPLETED ·Phase: PHASE2
-
Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy
NCT00630357 ·Status: COMPLETED ·Phase: PHASE4
-
An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy
NCT00210522 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures
NCT01964560 ·Status: COMPLETED ·Phase: PHASE3
-
Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
NCT00422422 ·Status: COMPLETED ·Phase: PHASE2